Učitavanje...
Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel): Results from a phase I safety trial
PURPOSE: To evaluate the safety and tolerability of intraocular delivery of ciliary neurotrophic factor (CNTF) using an encapsulated cell implant for the treatment of macular telangiectasia type 2. DESIGN: An open-labeled safety trial conducted in 2 centers enrolling 7 participants with macular tela...
Spremljeno u:
| Izdano u: | Am J Ophthalmol |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4361328/ https://ncbi.nlm.nih.gov/pubmed/25528956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2014.12.013 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|